Schedule 13G ownership disclosure
Keenova Therapeutics PLC
Ordinary Shares, $0.01 par value · CUSIP: G5890A102
Event date: 2025-07-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Hudson Bay Capital Management LP
Shares: 2,481,694.00 · Class: 6.30%
- Sander Gerber
Shares: 2,481,694.00 · Class: 6.30%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001393825-25-000034
- Form type
- SCHEDULE 13G/A
- Filer
- Hudson Bay Capital Management LP
- CIK
- CIK 1393825
- Filed
- Aug 07, 2025
- Reporting period
- Jul 31, 2025
- Description
- Schedule 13G beneficial ownership